News & Updates

Latest News & Updates

Viatris Inc. announced that Abevmy® is now available in Canada. Abevmy, is a biosimilar to Roche’s Avastin® (bevacizumab) and has been authorized for use by Health Canada across four oncology indications.

Many pharmacist-led and CAPhO-supported research initiatives are contributing significantly to advancing cancer care in Canada.

The clinical oncology pharmacist is part of a multidisciplinary team consisting of physicians, pharmacists, pharmacy technicians, nurses, social workers and dieticians from BC Cancer and Northern Health. 

A needs assessment on the management of chronic lymphocytic leukemia (CLL) developed by a multidisciplinary committee of fellow healthcare providers is available!

We are very pleased to announce that applications for the 2nd annual HOPE (Honouring Oncology Pharmacy Excellence) Awards in Pharmacy are now open! The HOPE Awards honour and recognize accomplishments of oncology pharmacists across Canada.

Can you identify hazardous drug contamination in less than 10 minutes? BD® HD Check is an easy-to-use system to protect your facility from the risk of hazardous drug exposure.

Apotex is proud to be delivering important savings to the Canadian Healthcare System, and to patients with Multiple Myeloma and Myelodysplastic Syndrome, with our MADE IN CANADA lenalidomide product.

The purpose of this study is to gain a better understanding of the febrile neutropenia treatment protocols used across Canada for adult patients receiving chemotherapy for solid organ cancers.

CAPhO members are invited to attend the Charting New Directions in the Treatment and Management of Chronic Lymphocytic Leukemia session hosted by AstraZeneca.

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market

Congratulations to all of the CAPhO members who received an Award in 2021